Capsaicin promotes the amyloidogenic route of brain amyloid precursor protein processing

Neurochemistry International

Volumn 54, Issue 7, 2009, Pages 426-430

  Pákáski, Magdolna ^a   Hugyecz, Marietta ^b   Sántha, Péter ^b   Jancsó, Gábor ^b   Bjelik, Annamária ^a   Domokos, Ágnes ^a   Janka, Zoltán ^a   Kálmán, János ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Secretase; Alzheimer's disease; Amyloid precursor protein; Capsaicin; Protein kinase C; Vanilloid receptor

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CAPSAICIN; MESSENGER RNA; PROTEIN KINASE C;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROCESSING; RAT;

ACTINS; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CAPSAICIN; MALE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STIMULATION, CHEMICAL;

RATTUS;

EID: 63149085560     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.01.012     Document Type: Article

References (57)

1. Begum A.N., Jones M.R., Lim G.P., Morihara T., Kim P., Heath D.D., Rock C.L., Pruitt M.A., Yang F., Hudspeth B., Hu S., Faull K.F., Teter B., Cole G.M., and Frautschy S.A. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J. Pharmacol. Exp. Ther. 326 (2008) 196-208
2. Beliczai Z., Varszegi S., Gulyas B., Halldin C., Kasa P., and Gulya K. Immunohistoblot analysis on whole human hemispheres from normal and Alzheimer diseased brains. Neurochem. Int. 53 (2008) 181-183
3. Bjelik A., Bereczki E., Gonda S., Juhász A., Rimanóczy A., Zana M., Csont T., Pákáski M., Boda K., Ferdinandy P., Dux L., Janka Z., Sántha M., and Kálmán J. Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis. Neurochem. Int. 49 (2006) 393-400
4. Bjelik A., Pákáski M., Berecki E., Gonda S., Juhász A., Rimanóczy A., Zana M., Janka Z., Sántha M., and Kálmán J. APP mRNA splicing is upregulated in the brain of biglycan transgenic mice. Neurochem. Int. 50 (2007) 1-4
5. Bojarski L., Herms J., and Kuznicki J. Calcium dysregulation in Alzheimer's disease. Neurochem. Int. 52 (2008) 621-633
6. Caterina M.J., and Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 24 (2001) 487-517
7. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
8. Checler F. Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65 (1995) 1431-1444
9. Chen M., and Fernandez H.L. Stimulation of beta-amyloid precursor protein alpha-processing by phorbol ester involves calcium and calpain activation. Biochem. Biophys. Res. Commun. 316 (2004) 332-340
10. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
11. Christen Y. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71 (2000) 621S-629S
12. Cole G.M., Morihara T., Lim G.P., Yang F., Begum A., and Frautschy S.A. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models. Ann. N. Y. Acad. Sci. 1035 (2004) 68-84
13. Cuajungco M.P., Fagét K.Y., Huang X., Tanzi R.E., and Bush A.I. Metal chelation as a potential therapy for Alzheimer's disease. Ann. N. Y. Acad. Sci. 920 (2000) 292-304
14. Dairam A., Fogel R., Daya S., and Limson J.L. Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. J. Agric. Food Chem. 56 (2008) 3350-3356
15. Fukumoto H., Cheung B.S., Hyman B.T., and Irizarry M.C. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59 (2002) 1381-1389
16. Garcia-Allosa M., Borrelli L.A., Rozkalne A., Hyman B.T., and Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 102 (2007) 1095-1104
17. Garcia-Allosa M., Robbins E.M., Zhang-Nunes S.X., Purcell S.M., Betensky R.A., Raju S., Prada C., Greenberg S.M., Bacskai B.J., and Frosch M.P. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis. 24 (2006) 516-524
18. Hardy J., and Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12 (1991) 383-388
19. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
20. Hess H.H., Lees M.B., and Derr J.E. A linear Lowry-Folin assay for both water-soluble and sodium dodecyl sulfate-solubilized proteins. Anal. Biochem. 85 (1978) 295-300
21. Huovila A.P., Turner A.J., Pelto-Huikko M., Kärkkäinen I., and Ortiz R.M. Shedding light on ADAM metalloproteinases. Trends Biochem. Sci. 30 (2005) 413-422
22. Ibarreta D., Duchén M., Ma D., Qiao L., Kozikowski A.P., and Etcheberrigaray R. Benzolactam (BL) enhances sAPP secretion in fibroblasts and in PC12 cells. Neuroreport 10 (1999) 1035-1040
23. Jancsó G., and Lawson S.N. Transganglionic degeneration of capsaicin-sensitive C-fiber primary afferent terminals. Neuroscience 39 (1990) 501-511
24. Jancsó G., and Lynn B. Possible use of capsaicin in pain therapy. C. J. Pain 3 (1987) 123-126
25. Jancsó G., Király E., and Jancsó-Gábor A. Direct evidence for an axonal site of action of capsaicin. Naunyn-Schmiedebergs Arch. Pharmacol. 313 (1980) 91-94
26. Jancsó N. Desensitization with capsaicin as a tool for studying the function of pain receptors. In: Lim R.K.S. (Ed). Pharmacology of Pain (1968), Blackwell Science Inc., Oxford
27. Jolly-Tornetta C., and Wolf B.A. Regulation of amyloid precursor protein (APP) secretion by protein kinase c alpha in human ntera 2 neurons (NT2N). Biochemistry 39 (2000) 7428-7435
28. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., and Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
29. Kuller L.H. Statins and dementia. Curr. Atheroscler. Rep. 9 (2007) 154-161
30. Lanni C., Mazzucchelli M., Porrello E., Govoni S., and Racchi M. Differential involvement of protein kinase C alpha and epsilon in the regulated secretion of soluble amyloid precursor protein. Eur. J. Biochem. 271 (2004) 3068-3075
31. Li R., Lindholm K., Yang L.B., Yue X., Citron M., Yan R., Beach T., Sue L., Sabbagh M., Cai H., Wong P., Price D., and Shen Y. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3632-3637
32. Lin J.K., Chen Y.C., Huang Y.T., and Lin-Shiau S.Y. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J. Cell Biochem. Suppl. 28-29 (1997) 39-48
33. Maheshwari R.K., Singh A.K., Gaddipati J., and Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 78 (2006) 2081-2087
34. Mahmmoud Y.A. Modulation of proteine kinase C by curcumin, inhibition and activation switched by calcium ions. Br. J. Pharmacol. 150 (2007) 200-208
35. Manjunatha H., and Srinivasan K. Hypolipidemic and antioxidant effects of dietary curcumin and capsaicin in induced hypercholesterolemic rats. Lipids 42 (2007) 1133-1142
36. Mancuso C., Bates T.E., Butterfield D.A., Calafato S., Cornelius C., De Lorenzo A., Dinkova Kostova A.T., and Calabrese V. Natural antioxidants in Alzheimer's disease. Expert. Opin. Investig. Drugs 16 (2007) 1921-1931
37. Marks N., and Berg M.J. Neurosecretases provide strategies to treat sporadic and familial Alzheimer disorders. Neurochem. Int. 52 (2008) 184-215
38. Mousavi M., and Hellström-Lindahl E. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro. Neurochem. Int. (2009) (Epub ahead of print)
39. Nagy I., Sántha P., Jancsó G., and Urbán L. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur. J. Pharmacol. 500 (2004) 351-369
40. Narlawar R., Baumann K., Schubenel R., and Schmidt B. Curcumin derivatives inhibit or modulate beta-amyloid precursor protein metabolism. Neurodegener. Dis. 4 (2007) 88-93
41. Narlawar R., Pickhardt M., Leuchtenberger S., Baumann K., Krause S., Dyrks T., Weggen S., Mandelkow E., and Schmidt B. Curcumin-derived pyrazoles and isoxazoles: Swiss army knives or blunt tools for Alzheimer's disease?. Chem. Med. Chem. 3 (2008) 165-172
42. Ono K., Hasegawa K., Naiki H., and Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J. Neurosci. Res. 75 (2004) 742-750
43. Pákáski M., and Kálmán J. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease. Neurochem. Int. 53 (2008) 103-111
44. Pereira C., Agostinho P., Moreira P.I., Cardoso S.M., and Oliveira C.R. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 383-403
45. Premkumar L.S., and Ahern G.P. Induction of vanilloid receptor channel activity by protein kinase C. Nature 408 (2000) 985-990
46. Racchi M., Mazzucchelli M., Pascale A., Sironi M., and Govoni S. Role of protein kinase C alpha in the regulated secretion of the amyloid precursor protein. Mol. Psychiatry 8 (2003) 209-216
47. Reid P.C., Urano Y., Kodama T., and Hamakubo T. Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins. J. Cell Mol. Med. 11 (2007) 383-392
48. Rossner S., Beck M., Stahl T., Mendla K., Schliebs R., and Bigl V. Constitutive overactivation of protein kinase C in guinea pig brain increases alpha-secretory APP processing without decreasing beta-amyloid generation. Eur. J. Neurosci. 12 (2000) 3191-3200
49. Sayre L.M., Perry G., and Smith M.A. Redox metals and neurodegenerative disease. Curr. Opin. Chem. Biol. 3 (1999) 220-225
50. Selkoe D.J. Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53 (1994) 438-447
51. Shivers B.D., Hilbich C., Multhaup G., Salbaum M., Beyreuther K., and Seeburg P.H. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. Eur. Mol. Biol. Organ. J. 7 (1988) 1365-1370
52. Sinjoanu R.C., Kleinschmidt S., Bitner R.S., Brioni J.D., Moeller A., and Ferreira A. The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons. Neurochem. Int. 53 (2008) 79-88
53. Sola C., Garcia-Ladona F.J., Mengod G., Probst A., Frey P., and Palacios J.M. Increased levels of the Kunitz protease inhibitor-containing beta APP mRNAs in rat brain following neurotoxic damage. Brain Res. Mol. Brain Res. 17 (1993) 41-52
54. Srinivasan K., Sambaiah K., and Chandrasekhara N. Spices as beneficial hypolipidemic food adjuncts: a review. Food Rev. Int. 20 (2004) 187-220
55. Szallasi A., and Blumberg P.M. Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules). Adv. Pharmacol. 24 (1993) 123-155
56. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., and Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286 (1999) 735-741
57. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., and Cole G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques and reduces amyloid in vivo. J. Biol. Chem. 280 (2005) 5892-5901